FDA.reportPublic FDA data

CYBERWHITE EX

Manufacturer
ESTEE LAUDER INC | ESTEE LAUDER COSMETICS, LTD | ESTEE LAUDER N.V. | Len-Ron Manufacturing Division of Aramis Inc. | Aramis Inc. | Northtec Bristol | Northtec Keystone | PADC 1 | Estee Lauder Pennsylvania Distribution Center 2 | Estee Lauder Cosmetics, Ltd. | Estee Lauder Cosmetics Distribution Center | Estee Lauder Kabushiki Kaisha | Whitman Laboratories Ltd. | Aveda Corporation
Effective date
2010-04-13
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:24:12

Label at a glance#

ProductCYBERWHITE EX EXTRA INTENSIVE BB CREME MULTI ACTION FORMULA SPF35
Active ingredientOCTINOXATE, OCTISALATE, ZINC OXIDE, OXYBENZONE, TITANIUM DIOXIDE
Label structure3 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENTS: OCTINOXATE 7.50% [] OCTISALATE 4.00% [] ZINC OXIDE 3.50% [] OXYBENZONE 2.50% [] TITANIUM DIOXIDE 1.10%

WARNINGS SECTION

WARNING: KEEP OUT OF EYES. STOP USE IF IRRITATION OCCURS. KEEP OUT OF REACH OF CHILDREN.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANEL

ESTEE LAUDER
CYBER WHITE EX

EXTRA INTENSIVE BB CREME

MULTI-ACTION
FORMULA
SPF 35


1.7 FL OZ. LIQ./50 ML


ESTEE LAUDER DIST.
NEW YORK, NY 10022

ESTEELAUDER.COM
WJRJ
FOLDING CARTON
FOLDING CARTON



Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 128C143799WJRJcarton.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11559-004-012019-10-21C16284748780-1956f9ecf-d4b5-621f-e053-dbdaa90a74ad05e6d02e-0b0a-4b4c-9ff4-967936d1848b

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11559-004-01CYBERWHITE EXEXTRA INTENSIVE BB CREME MULTI ACTION FORMULA SPF351 in 1 CARTONCREAM12
11559-004-02CYBERWHITE EXEXTRA INTENSIVE BB CREME MULTI ACTION FORMULA SPF3550 mL in 1 TUBECREAM502

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11559-004CYBERWHITE EX EXTRA INTENSIVE BB CREME MULTI ACTION FORMULA SPF35 (OCTINOXATE, OCTISALATE, ZINC OXIDE, OXYBENZONE, TITANIUM DIOXIDE) CREAM [ESTEE LAUDER INC]2Legacy NDC, 2 package rows20100413_05e6d02e-0b0a-4b4c-9ff4-967936d1848b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD512
OCTISALATEACTIVE INGREDIENT4X49Y0596W2
OXYBENZONEACTIVE INGREDIENT95OOS7VE0Y2
TITANIUM DIOXIDEACTIVE INGREDIENT15FIX9V2JP2
ZINC OXIDEACTIVE INGREDIENTSOI2LOH54Z2
OCTINOXATEACTIVE MOIETY4Y5P7MUD512
OCTISALATEACTIVE MOIETY4X49Y0596W2
OXYBENZONEACTIVE MOIETY95OOS7VE0Y2
TITANIUM DIOXIDEACTIVE MOIETY15FIX9V2JP2
ZINC OXIDEACTIVE MOIETYSOI2LOH54Z2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11559-00411559-004-02, 11559-004-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
OCTINOXATE4Y5P7MUD51ACTIB
OCTISALATE4X49Y0596WACTIB
ZINC OXIDESOI2LOH54ZACTIB
OXYBENZONE95OOS7VE0YACTIB
TITANIUM DIOXIDE15FIX9V2JPACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
6be0a7e4-4ea4-4d4c-b518-bad45782b6fb05e6d02e-0b0a-4b4c-9ff4-967936d1848b2010-04-13WarningsExact identifier
spl id: 6be0a7e4-4ea4-4d4c-b518-bad45782b6fb
spl set id: 05e6d02e-0b0a-4b4c-9ff4-967936d1848b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.